ODT’s Most-Read Stories This Week—Oct. 19

ODT’s digital traffic this past week confirmed a longstanding theory about subject matter: Conflict and controversy make for captivating content.
 
Case in point: The brewing legal battle between Treace Medical Concepts and Stryker Corp. Treace Medical topped site traffic with its lawsuit against Stryker and subsidiary Wright Medical, alleging infringement of nine patents related to Treace’s Lapiplasty 3D Bunion Correction technologies and unfair competition. Filed in U.S. District Court for the District of New Jersey, the suit seeks injunctive relief and damages. The company, according to Treace Founder/CEO John T. Treace, was the first to develop, patent, and introduce an instrumented 3D bunion correction system, creating an entirely new segment of the U.S. bunion market. Treace claims it built its market presence from zero to a standard of care for bunion surgery over the last 10 years.

Besides the lawsuit, website loyalists favored featured firsts: Catalyst OrthoSciences, for example, produced significant pageviews by gaining FDA 510(k) clearance for its Catalyst fracture shoulder system and conducting its first surgeries with the implant. A reverse fracture arthroplasty system for treating proximal humeral fractures, the product includes tuberosity-specific fossa designed to maximize tuberosity contact and healing to a porous surface. The company’s patented tuberosity retention rails are designed to further restrict tuberosity post-operatively.

SI-BONE Inc. followed suit in attracting readers by marking the first-in-patient procedures with its FDA-designated breakthrough device, the iFuse TORQ TNT Implant System, designed to address the anatomic and biomechanical challenges of pelvic fragility fractures, particularly in patients with poor bone quality. SI-Bone claims the product offers a significant advancement over traditional cannulated screws.

VISIE and Paragon 28 enticed cybervisitors with product firsts. VISIE (formerly Advanced Scanners), unveiled Continuous Anatomic Auto Tracking technology for robotic-assisted TKA, while Paragon 28 launched the Phantom fibula nail system, which was designed as a less invasive option to treat the fibula during an ankle fracture.

1. Treace Medical Alleges Patent Infringement, Unfair Competition by Stryker

2. Catalyst Ortho’s Shoulder Fracture System Wins FDA Nod, Has 1st Cases

3. VISIE Introduces Continuous Anatomic Auto Tracking for Robotic-Assisted TKA

4. Paragon 28 Launches Phantom Fibula Nail System for Ankle Fractures

5. Breakthrough Device for Pelvic Fracture Fixation Used in First Patient Implant